Open AccessFactors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration
Author(s) -
Onur Polat,
Sibel İnan,
Serkan Özcan,
Mustafa Doğan,
Tuncay Küsbeci,
Güliz Fatma Yavaş,
Ümit Ubeyt İnan
Publication year - 2017
Publication title -
turkish journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.654
H-Index - 10
eISSN - 2147-2661
pISSN - 1300-0659
DOI - 10.4274/tjo.28003
Subject(s) - medicine , pro re nata , macular degeneration , ranibizumab , regimen , visual acuity , compliance (psychology) , pediatrics , ophthalmology , chemotherapy , bevacizumab , psychology , social psychology
To determine factors influencing compliance in patients with neovascular age-related macular degeneration (n-AMD) undergoing intravitreal anti-vascular endothelial growth factor (VEGF) therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom